Learn more about whether Envista Holdings Corporation or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
In a report released yesterday, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Envista Holdings (NVST – Research Report), with a ...
Q4 2024 Management View CEO Paul Keel reported Q4 performance in line with expectations, achieving 2% core growth and a 13.9% adjusted EBITDA margin. The implants business, particularly in North ...
The most significant addition was Envista Holdings Corp (NYSE:NVST), with 880,177 shares, accounting for 0.06% of the portfolio and a total value of $16.98 million. The second largest addition to the ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report) and ...
Learn more about whether LeMaitre Vascular, Inc. or Envista Holdings Corporation is a better investment based on AAII's A+ ...
Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2024. "In Q4 2024 ...
The Brea, California-based company said it had net income of 1 cent per share. Earnings, adjusted for amortization costs and restructuring costs, came to 24 cents per share. The results exceeded Wall ...
Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista will discuss these results on a conference ...
Envista Holdings Corporation (NVST) stock price is 21.37 and Envista Holdings Corporation (NVST) 10-day simple moving average is 20.73. Envista Holdings Corporation (NVST) stock price is 21.37 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results